MSC therapy ameliorates experimental gouty arthritis hinting an early COX-2 induction

Objective The specific effect of Adipose-Derived Mesenchymal Stem Cells (Ad-MSC) on acute joint inflammation, where the response mostly depends on innate immunity activation, remains elusive. The pathogenesis of gouty arthritis, characterized by the deposition of monosodium urate (MSU) crystals in the joints, associated to acute flares, has been associated to NLRP3 inflammasome activation and subsequent amplification of the inflammatory response. Our aim was to study the effect of human Ad-MSC administration in the clinical inflammatory response of rabbits after MSU injection, and the molecular mechanisms involved. Methods Ad-MSC were administered by intraarterial route shortly after intraarticular MSU crystal injections. Joint and systemic inflammation was sequentially studied, and the mechanisms involved in NLRP3 inflammasome activation, and the synthesis of inflammatory mediators were assessed in the synovial membranes 72h after insult. Ad-MSC and THP-1-derived macrophages stimulated with MSU were co-cultured in transwell system. Results A single systemic dose of Ad-MSC accelerated the resolution of local and systemic inflammatory response. In the synovial membrane, Ad-MSC promoted alternatively M2 macrophage presence, inhibiting NLRP3 inflammasome and inducing the production of anti-inflammatory cytokines, such as IL-10 or TGF-β, and decreasing nuclear factor-κB activity. Ad-MSC induced a net anti-inflammatory balance in MSU-stimulated THP-1 cells, with a higher increase in IL-10 and IDO expression than that observed for IL-1β and TNF. Conclusion Our in vivo and in vitro results showed that a single systemic dose of Ad-MSC decrease the intensity and duration of the inflammatory response by an early local COX-2 upregulation and PGE2 release. Ad-MSCs suppressed NF-kB activity, NLRP3 inflammasome, and promoted the presence of M2 alternative macrophages in the synovium. Therefore, this therapeutic approach could be considered as a pharmacological alternative in patients with comorbidities that preclude conventional treatment.

[1]  L. Pączek,et al.  The Role of COX-2 and PGE2 in the Regulation of Immunomodulation and Other Functions of Mesenchymal Stromal Cells , 2023, Biomedicines.

[2]  C. Shao,et al.  Mesenchymal stem/stromal cells primed by inflammatory cytokines alleviate psoriasis-like inflammation via the TSG-6-neutrophil axis , 2022, Cell Death & Disease.

[3]  M. Heke,et al.  Stem cell-based therapy for human diseases , 2022, Signal Transduction and Targeted Therapy.

[4]  J. Tu,et al.  Research progress of the application of mesenchymal stem cells in chronic inflammatory systemic diseases , 2022, Stem Cell Research & Therapy.

[5]  E. Jones,et al.  Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors? , 2021, Frontiers in Immunology.

[6]  R. Yañez,et al.  Enhanced anti-inflammatory effects of mesenchymal stromal cells mediated by the transient ectopic expression of CXCR4 and IL10 , 2021, Stem cell research & therapy.

[7]  Mengting Liu,et al.  Human umbilical cord mesenchymal stem cells ameliorate acute liver failure by inhibiting apoptosis, inflammation and pyroptosis , 2021, Annals of translational medicine.

[8]  M. Lopez-Santalla,et al.  Mesenchymal Stem/Stromal Cells for Rheumatoid Arthritis Treatment: An Update on Clinical Applications , 2020, Cells.

[9]  J. Bueren,et al.  Cell Therapy With Mesenchymal Stem Cells Induces an Innate Immune Memory Response That Attenuates Experimental Colitis in the Long Term , 2020, Journal of Crohn's & colitis.

[10]  H. Lee,et al.  Mesenchymal Stem and Stromal Cells Harness Macrophage-Derived Amphiregulin to Maintain Tissue Homeostasis. , 2020, Cell reports.

[11]  Young-Min Hyun,et al.  In vivo monitoring of dynamic interaction between neutrophil and human umbilical cord blood-derived mesenchymal stem cell in mouse liver during sepsis , 2020, Stem Cell Research & Therapy.

[12]  M. Cutolo,et al.  Macrophage M1/M2 polarization and rheumatoid arthritis: A systematic review. , 2019, Autoimmunity reviews.

[13]  G. Herrero-Beaumont,et al.  Targeting chronic innate inflammatory pathways, the main road to prevention of osteoarthritis progression. , 2019, Biochemical pharmacology.

[14]  M. Dahlke,et al.  Immunomodulation by Mesenchymal Stem Cells (MSCs): Mechanisms of Action of Living, Apoptotic, and Dead MSCs , 2019, Front. Immunol..

[15]  G. Herrero-Beaumont,et al.  Inhibition of pSTAT1 by tofacitinib accounts for the early improvement of experimental chronic synovitis , 2019, Journal of Inflammation.

[16]  Dunfang Zhang,et al.  The Immunomodulatory Properties of Mesenchymal Stem Cells , 2018, Stem cells international.

[17]  G. Herrero-Beaumont,et al.  Validation of Musculoskeletal Ultrasound in the Assessment of Experimental Gout Synovitis. , 2018, Ultrasound in medicine & biology.

[18]  S. Baik,et al.  Adipose-derived stem cells ameliorate colitis by suppression of inflammasome formation and regulation of M1-macrophage population through prostaglandin E2. , 2018, Biochemical and biophysical research communications.

[19]  Yufang Shi,et al.  Kynurenic acid, an IDO metabolite, controls TSG-6-mediated immunosuppression of human mesenchymal stem cells , 2017, Cell Death & Differentiation.

[20]  G. Herrero-Beaumont,et al.  Increased synovial lipodystrophy induced by high fat diet aggravates synovitis in experimental osteoarthritis , 2017, Arthritis Research & Therapy.

[21]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[22]  Y. Mu,et al.  Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats , 2017, Stem Cell Research & Therapy.

[23]  B. Levy,et al.  PGE2 production at sites of tissue injury promotes an anti-inflammatory neutrophil phenotype and determines the outcome of inflammation resolution in vivo , 2017, Science Advances.

[24]  F. Martinon,et al.  Inflammation in gout: mechanisms and therapeutic targets , 2017, Nature Reviews Rheumatology.

[25]  G. Herrero-Beaumont,et al.  Tofacitinib restores the inhibition of reverse cholesterol transport induced by inflammation: understanding the lipid paradox associated with rheumatoid arthritis , 2017, British journal of pharmacology.

[26]  H. Anders,et al.  Molecular Pathophysiology of Gout. , 2017, Trends in molecular medicine.

[27]  A. Barbero,et al.  Adipose stromal cells mediated switching of the pro-inflammatory profile of M1-like macrophages is facilitated by PGE2: in vitro evaluation. , 2017, Osteoarthritis and cartilage.

[28]  L. Ding,et al.  Exosomal miR‐146a Contributes to the Enhanced Therapeutic Efficacy of Interleukin‐1β‐Primed Mesenchymal Stem Cells Against Sepsis , 2017, Stem cells.

[29]  Shengping Lin,et al.  Intravenous hMSCs Ameliorate Acute Pancreatitis in Mice via Secretion of Tumor Necrosis Factor-α Stimulated Gene/Protein 6 , 2016, Scientific Reports.

[30]  Anoop Babu Vasandan,et al.  Human Mesenchymal stem cells program macrophage plasticity by altering their metabolic status via a PGE2-dependent mechanism , 2016, Scientific Reports.

[31]  K. Kang,et al.  Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis , 2016, Cell Death & Disease.

[32]  Yao Cheng,et al.  Bone marrow stromal cells attenuate LPS-induced mouse acute liver injury via the prostaglandin E 2-dependent repression of the NLRP3 inflammasome in Kupffer cells. , 2016, Immunology letters.

[33]  M. Chopp,et al.  Neurorestorative Responses to Delayed Human Mesenchymal Stromal Cells Treatment of Stroke in Type 2 Diabetic Rats , 2016, Stroke.

[34]  Tao-Sheng Li,et al.  Cardiosphere-Derived Cells Facilitate Heart Repair by Modulating M1/M2 Macrophage Polarization and Neutrophil Recruitment , 2016, PloS one.

[35]  K. Leung,et al.  Rabbit M1 and M2 macrophages can be induced by human recombinant GM‐CSF and M‐CSF , 2016, FEBS open bio.

[36]  U. Galderisi,et al.  Clinical Trials with Mesenchymal Stem Cells: An Update , 2016, Cell transplantation.

[37]  K. Le Blanc,et al.  Mesenchymal stromal cells and the innate immune response. , 2015, Immunology letters.

[38]  P. Sly,et al.  Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages. , 2015, American journal of respiratory cell and molecular biology.

[39]  G. Schett,et al.  Why does the gout attack stop? A roadmap for the immune pathogenesis of gout , 2015, RMD Open.

[40]  John C McGrath,et al.  Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP , 2015, British journal of pharmacology.

[41]  M. Gutierrez,et al.  Animal model of acute gout reproduces the inflammatory and ultrasonographic joint changes of human gout , 2015, Arthritis Research & Therapy.

[42]  M. Saleh,et al.  Advances in Nod-like receptors (NLR) biology. , 2014, Cytokine & growth factor reviews.

[43]  D. Prockop,et al.  Mesenchymal Stem/Stromal Cells Inhibit the NLRP3 Inflammasome by Decreasing Mitochondrial Reactive Oxygen Species , 2014, Stem cells.

[44]  S. Tamura,et al.  A synthetic tryptophan metabolite reduces hemorrhagic area and inflammation after pulmonary radiofrequency ablation in rabbit nonneoplastic lungs , 2014, Japanese Journal of Radiology.

[45]  D. Prockop,et al.  Concise Review: Two negative feedback loops place mesenchymal stem/stromal cells at the center of early regulators of inflammation , 2013, Stem cells.

[46]  G. Herrero-Beaumont,et al.  Hypercholesterolemia boosts joint destruction in chronic arthritis. An experimental model aggravated by foam macrophage infiltration , 2013, Arthritis Research & Therapy.

[47]  Mark Turmaine,et al.  Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model , 2013, Proceedings of the National Academy of Sciences.

[48]  D. Prockop,et al.  Human Mesenchymal Stem/Stromal Cells Cultured as Spheroids are Self‐activated to Produce Prostaglandin E2 that Directs Stimulated Macrophages into an Anti‐inflammatory Phenotype , 2012, Stem cells.

[49]  G. Herrero-Beaumont,et al.  RANKL synthesized by articular chondrocytes contributes to juxta-articular bone loss in chronic arthritis , 2012, Arthritis Research & Therapy.

[50]  L. Punzi,et al.  Cytokine levels in human synovial fluid during the different stages of acute gout: role of transforming growth factor β1 in the resolution phase , 2012, Annals of the rheumatic diseases.

[51]  A. Bierhaus,et al.  Modulation of Macrophage Efferocytosis in Inflammation , 2011, Front. Immun..

[52]  D. Prockop,et al.  Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-κB signaling in resident macrophages. , 2011, Blood.

[53]  Cheng-Han Wu,et al.  Spontaneous resolution of acute gouty arthritis is associated with rapid induction of the anti-inflammatory factors TGFβ1, IL-10 and soluble TNF receptors and the intracellular cytokine negative regulators CIS and SOCS3 , 2011, Annals of the rheumatic diseases.

[54]  S. Steiger,et al.  Monosodium urate monohydrate crystal-recruited noninflammatory monocytes differentiate into M1-like proinflammatory macrophages in a peritoneal murine model of gout. , 2011, Arthritis and rheumatism.

[55]  G. Herrero-Beaumont,et al.  Chronic arthritis aggravates vascular lesions in rabbits with atherosclerosis: a novel model of atherosclerosis associated with chronic inflammation. , 2008, Arthritis and rheumatism.

[56]  G. Burmester,et al.  Synovitis score: discrimination between chronic low‐grade and high‐grade synovitis , 2006, Histopathology.

[57]  F. Martinon,et al.  Gout-associated uric acid crystals activate the NALP3 inflammasome , 2006, Nature.

[58]  John Savill,et al.  Resolution of inflammation: the beginning programs the end , 2005, Nature Immunology.

[59]  Charles N. Serhan,et al.  Lipid mediator class switching during acute inflammation: signals in resolution , 2001, Nature Immunology.

[60]  R. Deans,et al.  Mesenchymal stem cells: biology and potential clinical uses. , 2000, Experimental hematology.

[61]  T. Langmann,et al.  Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro‐ and antiinflammatory stimuli , 2000, Journal of leukocyte biology.

[62]  D. Gilroy,et al.  Inducible cyclooxygenase may have anti-inflammatory properties , 1999, Nature Medicine.

[63]  A I Caplan,et al.  Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. , 1995, Bone marrow transplantation.

[64]  E. Kelly,et al.  an update on , 2014 .

[65]  W. Martin,et al.  Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout. , 2009, Arthritis and rheumatism.

[66]  Krisztián Németh,et al.  Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production , 2009, Nature Medicine.

[67]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[68]  G. Herrero-Beaumont,et al.  Anti-inflammatory effect of a PAF receptor antagonist and a new molecule with antiproteinase activity in an experimental model of acute urate crystal arthritis. , 1996, Journal of lipid mediators and cell signalling.